You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Dosage of heparin for patency of the totally implanted central venous catheter in cancer patients
Contributor:
Oliveira, Francisca Jane Gomes de;
Rodrigues, Andrea Bezerra;
Ramos, Islane Costa;
Caetano, Joselany Áfio
Published:
FapUNIFESP (SciELO), 2020
Published in:
Revista Latino-Americana de Enfermagem, 28 (2020)
Language:
Not determined
DOI:
10.1590/1518-8345.3326.3304
ISSN:
1518-8345
Origination:
Footnote:
Description:
Objective: to analyze the evidence available in the literature about the lowest necessary dose of heparin to maintain the patency of the totally implanted central venous catheter in adult cancer patients. Method: an integrative literature review, carried out in the following databases: Literatura Latino-Americana e do Caribe em Ciências de Saúde, Sciverse Scopus, Web of Science, Cumulative Index to Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials, including thirteen studies. Results: the evidence showed that the dose of heparin (300 IU/ml) is the most used in maintaining the patency of the totally implanted central venous catheter. Conclusion: according to the selected studies, the lowest dose of heparin found in maintaining the patency of the totally implanted central venous catheter in cancer patients was 10 UN/ml with a volume of 5 ml of the heparin solution.